Literature DB >> 2914483

Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study.

M A Gómez-Sánchez1, M J Mestre de Juan, C Gómez-Pajuelo, J I López, M J Díaz de Atauri, F J Martínez-Tello.   

Abstract

Clinical and pathologic findings in seven patients who died of severe pulmonary artery hypertension due to toxic oil syndrome are assessed. These cases correspond to a late stage of evolution of the disease characterized by progressive deterioration in clinical features--increasing dyspnea, chest pain, syncope, and death (in low-output heart failure). The main pathologic pulmonary vascular findings consisted of plexiform lesions, thromboses, and venous lesions. Endothelial damage induced by the toxic agents is suggested as an initial causative mechanism, perpetuated by intimal proliferation and in situ thrombosis. Plexiform lesions appear late and active histologically. This new cause of pulmonary artery hypertension, with pathologic findings similar to those found in primary pulmonary hypertension, may help in understanding the pathophysiology of this unknown disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914483     DOI: 10.1378/chest.95.2.325

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  The treatment of primary pulmonary hypertension.

Authors:  N G Uren; C M Oakley
Journal:  Br Heart J       Date:  1991-08

Review 2.  Dietary pulmonary hypertension.

Authors:  J M Kay
Journal:  Thorax       Date:  1994       Impact factor: 9.139

3.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

4.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.